Sobrecrecimiento bacteriano en trastornos funcionales del intestino

Background: Recent studies have described a high percentage of small intestinal bacterial overgrowth (SIBO) in patients with irritable bowel syndrome (IBS). However, the prevalence of SIBO has not been well established in other functional disorders. Aim: To evaluate the prevalence of SIBO in patient...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Madrid,Ana María, Defilippi C,Carlos, Defilippi G,Claudia, Slimming A,Jocelyn, Quera P,Rodrigo
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2007
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872007001000003
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872007001000003
record_format dspace
spelling oai:scielo:S0034-988720070010000032007-12-20Sobrecrecimiento bacteriano en trastornos funcionales del intestinoMadrid,Ana MaríaDefilippi C,CarlosDefilippi G,ClaudiaSlimming A,JocelynQuera P,Rodrigo Intestinal bacterial overgrowth Irritable bowel syndrome Lactulose tolerance test Background: Recent studies have described a high percentage of small intestinal bacterial overgrowth (SIBO) in patients with irritable bowel syndrome (IBS). However, the prevalence of SIBO has not been well established in other functional disorders. Aim: To evaluate the prevalence of SIBO in patients with different functional gastrointestinal disorders (FGID). Material and methods: Patients with FGID completed a self-administered questionnaire providing information to diagnose functional disorders on the basis of Rome II criteria. SIBO was assessed using a standardized lactulose breath test. A basal value of breath hydrogen (H2) >20 ppm and/or two lectures of HZ values >20 ppm during the first 60 minutes were considered suggestive of SIBO. Results: We studied 367 patients with a mean age of 50 years (87% females). Of these, 225 had IBS (45 constipation predominant, 121 diarrhea predominant and 59 alternating type), 33 had functional constipation, 83 had functional bloating and 26 had functional diarrhea. SIBO was found in 76% of patients with IBS, 73% of those with functional constipation, 69% of those with functional diarrhea and 68% of those with functional bloating. Conclusions: This study confirms a high percentage of SIBO in patients with IBS and other FGID. The eradication of SIBO should be considered as a therapeutic tool in these patientsinfo:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.135 n.10 20072007-10-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872007001000003es10.4067/S0034-98872007001000003
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Intestinal bacterial overgrowth
Irritable bowel syndrome
Lactulose tolerance test
spellingShingle Intestinal bacterial overgrowth
Irritable bowel syndrome
Lactulose tolerance test
Madrid,Ana María
Defilippi C,Carlos
Defilippi G,Claudia
Slimming A,Jocelyn
Quera P,Rodrigo
Sobrecrecimiento bacteriano en trastornos funcionales del intestino
description Background: Recent studies have described a high percentage of small intestinal bacterial overgrowth (SIBO) in patients with irritable bowel syndrome (IBS). However, the prevalence of SIBO has not been well established in other functional disorders. Aim: To evaluate the prevalence of SIBO in patients with different functional gastrointestinal disorders (FGID). Material and methods: Patients with FGID completed a self-administered questionnaire providing information to diagnose functional disorders on the basis of Rome II criteria. SIBO was assessed using a standardized lactulose breath test. A basal value of breath hydrogen (H2) >20 ppm and/or two lectures of HZ values >20 ppm during the first 60 minutes were considered suggestive of SIBO. Results: We studied 367 patients with a mean age of 50 years (87% females). Of these, 225 had IBS (45 constipation predominant, 121 diarrhea predominant and 59 alternating type), 33 had functional constipation, 83 had functional bloating and 26 had functional diarrhea. SIBO was found in 76% of patients with IBS, 73% of those with functional constipation, 69% of those with functional diarrhea and 68% of those with functional bloating. Conclusions: This study confirms a high percentage of SIBO in patients with IBS and other FGID. The eradication of SIBO should be considered as a therapeutic tool in these patients
author Madrid,Ana María
Defilippi C,Carlos
Defilippi G,Claudia
Slimming A,Jocelyn
Quera P,Rodrigo
author_facet Madrid,Ana María
Defilippi C,Carlos
Defilippi G,Claudia
Slimming A,Jocelyn
Quera P,Rodrigo
author_sort Madrid,Ana María
title Sobrecrecimiento bacteriano en trastornos funcionales del intestino
title_short Sobrecrecimiento bacteriano en trastornos funcionales del intestino
title_full Sobrecrecimiento bacteriano en trastornos funcionales del intestino
title_fullStr Sobrecrecimiento bacteriano en trastornos funcionales del intestino
title_full_unstemmed Sobrecrecimiento bacteriano en trastornos funcionales del intestino
title_sort sobrecrecimiento bacteriano en trastornos funcionales del intestino
publisher Sociedad Médica de Santiago
publishDate 2007
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872007001000003
work_keys_str_mv AT madridanamaria sobrecrecimientobacterianoentrastornosfuncionalesdelintestino
AT defilippiccarlos sobrecrecimientobacterianoentrastornosfuncionalesdelintestino
AT defilippigclaudia sobrecrecimientobacterianoentrastornosfuncionalesdelintestino
AT slimmingajocelyn sobrecrecimientobacterianoentrastornosfuncionalesdelintestino
AT queraprodrigo sobrecrecimientobacterianoentrastornosfuncionalesdelintestino
_version_ 1718436342884466688